Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

By News Health
2 months Ago

(MedPage Today) — NEW ORLEANS — Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy.
In patients with relatively…

Source link : https://www.medpagetoday.com/meetingcoverage/isc/119779

Author :

Publish date : 2026-02-06 20:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Can GLP-1 Drugs Prevent Worsening Mental Illness? Perhaps, Study Suggests

Indian Health Service Prepping to Break Ground to Replace Aging Medical Buildings

Plunge in Antiviral Scripts for Hep C Points to Unmet Treatment Needs

Survey Examines Current Practice in Skin of Color Clinics

Pediatrician Who Traded Drugs for Sex Gets 20 Years in Prison

A Ubiquitous Alcohol Emerges as Allergen of 2026